arrow
J

Jaap W. Groothoff

chu lyon
H指数:55
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

APOL1 kidney risk variants and outcomes in children with congenital anomalies of the kidney and urinary tract

先天性肾脏和尿路异常儿童的APOL1肾脏风险变异和结局

2026-01-140
PRE
Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study

原发性高草酸尿症I型的自然史:一项回顾性研究

2025-09-180
OAAI
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands

原发性高草酸尿症1型的Lumasiran受控获取:对荷兰罕见病药物新获取途径的评估

2025-03-220
PRE
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial

Lumasiran治疗晚期原发性高草酸尿症1型的有效性与安全性:ILLUMINATE-C三期试验24个月随访研究

2025-03-130
PRE
Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN

全球原发性高草酸尿症的管理:代表OxalEurope、ERA的G&K Working Group及ESPN开展的调查

2025-02-211
PRE
Intrafamilial Disease Heterogeneity in Primary Hyperoxaluria Type 1
2024-10-010
OAAI
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries

在儿童期开始进行脂蛋白单采的纯合子家族性高胆固醇血症患者的心血管结局: 来自两个注册中心的国际队列的长期随访

2024-07-015
PRE
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN

纯合子家族性高胆固醇血症儿童脂蛋白单采术的临床实践建议: 来自ERKNet和ESPN的专家共识声明

2024-05-0110
OAAI
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
2023-10-017
OAAI